SARS-CoV-2 3CLpro-IN-2
Product Specifications
UNSPSC Description
SARS-CoV-2 3CLpro-IN-2 (Compound 1) is a potent inhibitor of 3CL protease. SARS-CoV-2 3CLpro-IN-2 has the potential for the research of SARS-CoV-2 diseases[1].
Target Antigen
SARS-CoV
Type
Reference compound
Related Pathways
Anti-infection
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/sars-cov-2-3clpro-in-2.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CNC(CN1C(N/C(N(C1=O)CC2=CC(F)=C(C(F)=C2)F)=N\C3=C(C=C(C=C3)OC(F)F)C)=O)=O
Molecular Weight
499.39
References & Citations
[1]Tyndall JDA. S-217622, a 3CL Protease Inhibitor and Clinical Candidate for SARS-CoV-2. J Med Chem. 2022 May 12;65(9):6496-6498.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-146998/SARS-CoV-2-3CLpro-IN-2-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-146998/SARS-CoV-2-3CLpro-IN-2-SDS-MedChemExpress.pdf
Clinical Information
No Development Reported
CAS Number
2765088-93-3
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items